Related Experiment Video
Updated: May 9, 2026

Portable Paper-Based Immunoassay Combined with Smartphone Application for Colorimetric and Quantitative Detection of Dengue NS1 Antigen
Published on: January 26, 2024
Clinical spectrum of incomplete Kawasaki disease in Thailand
Rekwan Sittiwangkul1, Yupada Pongprot, Suchaya Silvilairat
1Chiang Mai University Hospital, Thailand.
Insights
Incomplete Kawasaki disease (KD) is harder to diagnose, leading to delayed treatment and a higher risk of large coronary aneurysms. Early diagnosis is crucial for managing KD patients effectively.
Area of Science:
- Pediatrics
- Cardiology
- Rheumatology
Background:
- Incomplete Kawasaki disease (KD) poses diagnostic challenges, potentially delaying treatment and leaving the risk of coronary artery aneurysms unclear.
- Accurate diagnostic criteria are vital for timely intervention in KD patients.
Purpose of the Study:
- To compare clinical, laboratory, and echocardiographic features of incomplete KD versus classic KD.
- To identify risk factors associated with incomplete KD.
Main Methods:
- Retrospective review of 208 KD patients' medical records from January 2001 to December 2009.
- Incomplete KD defined as having three or fewer major diagnostic criteria.
Main Results:
- 29% of KD patients had incomplete KD, with a higher male proportion and later diagnosis (mean day 9.0 vs 7.2).
- Delayed diagnosis (>10 days) was more frequent in incomplete KD (21% vs 10%).
- While overall coronary artery abnormalities were similar, large aneurysms were significantly more common in incomplete KD (10% vs 1%).
Conclusions:
- Incomplete KD and classic KD share similar disease spectra but incomplete forms are harder to diagnose.
- Delayed diagnosis in incomplete KD increases the risk of developing large coronary aneurysms.
Background:
Inadequate diagnostic criteria in incomplete Kawasaki disease (KD) patients may lead to misdiagnosis and delayed treatment. However, the risk of coronary artery aneurysm in these patients remains uncertain.
Aim:
To investigate differences in clinical, laboratory and echocardiographic variables between patients with incomplete KD and classic KD.
Method:
The medical records of 208 KD patients treated between January 2001 and December 2009 in the Department of Pediatrics, Chiang Mai University Hospital were reviewed retrospectively. Patients with three or fewer major criteria were defined as having incomplete KD.
Results:
Of the 208 KD patients, 61 (29%) had incomplete KD. In those with incomplete KD, a significantly higher proportion were male (73.8% vs 59.2%, P = 0.03), the diagnosis was made later [mean (SD) day 9.0 (4.2) vs 7.2 (2.5), P = 0.003], there was a higher rate of delayed diagnosis (>10 days, 21% vs 10%, P = 0.02) and the presence of five major criteria was less common. The proportion of associated symptoms (irritability, upper respiratory tract symptoms, diarrhoea, vomiting and reactivation of BCG) and laboratory findings (pyuria, haemoglobin level, white blood count, polymorphonuclear cells, platelet count, erythrocyte sedimentation rate and serum albumin) were comparable in patients with incomplete KD and classic KD. The incomplete KD group tended to have a higher proportion of coronary artery abnormalities but the difference was not statistically significant (38% vs 25%, P = 0.09). However, a significantly greater proportion of the group with incomplete KD had large aneurysms (10% vs 1%, P = 0.009).
Conclusions:
Incomplete KD and classic KD have the same disease spectrum. Owing to the absence of some major criteria, incomplete KD can be more difficult to diagnose, which can result in delayed diagnosis and a greater risk of large coronary aneurysms.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Chronic Kidney Disease II: Clinical Manifestations